about
Genetic fixity in the human major histocompatibility complex and block size diversity in the class I region including HLA-E.IgG subclass antibodies to human and bacterial HSP60 are not associated with disease activity and progression over time in axial spondyloarthritis.Nanoparticles for transcutaneous vaccination.Generating aptamers for recognition of virus-infected cells.Inflammation and arthritis: perspectives of the glycobiologist.Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis.Detection of Chlamydophila pneumoniae in patients with arthritis: significance and diagnostic value.Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis.
P2860
Q33281963-E2495AB2-9A57-4A17-8F5E-80DA32FF8A4AQ33765701-60A81C37-1B2E-450D-80EA-16E6E34E3CCEQ37274692-463D4AAC-25CD-4D9B-8879-06386766CC1BQ37407770-216E8328-3862-48E3-899F-6F9F1548E34CQ37754703-655F1453-1CA4-4DDD-8D8D-40DEA33B617CQ37848604-736EB5DC-2BB2-43C7-ADA0-4FD9752562FCQ37853259-2412BF85-87A9-431E-ABA9-F97AA837983BQ46439316-43951658-9620-41CB-801B-2C2F9194396B
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Mechanisms of disease: infection and spondyloarthritis.
@ast
Mechanisms of disease: infection and spondyloarthritis.
@en
type
label
Mechanisms of disease: infection and spondyloarthritis.
@ast
Mechanisms of disease: infection and spondyloarthritis.
@en
prefLabel
Mechanisms of disease: infection and spondyloarthritis.
@ast
Mechanisms of disease: infection and spondyloarthritis.
@en
P2860
P356
P1476
Mechanisms of disease: infection and spondyloarthritis
@en
P2093
Robert D Inman
P2860
P304
P356
10.1038/NCPRHEUM0118
P577
2006-03-01T00:00:00Z